Inovio Pharmaceuticals, Inc. · NASDAQ:INO
Janus Henderson Group PLC reported a 6.20% stake in Inovio Pharmaceuticals, Inc. (Schedule 13G)
Event Sep 30, 2025 · Filed Nov 14, 2025
Janus Henderson Group PLC reported a 6.20% stake in Inovio Pharmaceuticals, Inc., 3,266,260 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G).
- Stake
- 6.20%
- Shares
- 3,266,260
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 6.20% | 3,266,260 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 5.30% | 2,802,530 |
Source
Related
- Inovio Pharmaceuticals, Inc.
- Janus Henderson Group PLC
- Inovio Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Dec 8, 2025
- Schedule 13G/A · Adage Capital Management, L.P. · Aug 12, 2026
- Schedule 13G · Ra Capital Management, L.P. · Aug 7, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Form 4 · Humeau Laurent · May 21, 2026